TWiV 755: COVID-19 clinical update #62 with Dr. Daniel Griffin
In COVID-19 clinical update #62, Daniel Griffin covers outdoor transmission of the virus, safe use of NSAIDS, expansion of Pfizer/BioNTech vaccine to include 12-15 year olds, post-disease Mucormycosis...
15 Touko 202141min
TWiV 754: Tuesday two: SARS-CoV-2 and TLR2
TWiV discusses the finding that the envelope (E) protein of SARS-CoV-2 is sensed by toll-like receptor 2 on cells, leading to the production of inflammatory cytokines that cause damage to cells and ti...
13 Touko 20211h 36min
TWiV 753: The ferret nose where the virus goes
TWiV revisits Brazil's rejection of Sputnik vaccine, examines influenza transmission via the air from the nasal epithelium of ferrets, and a history of accidental releases of polioviruses and their re...
9 Touko 20211h 43min
TWiV 752: COVID-19 clinical update #61 with Dr. Daniel Griffin
In COVID-19 clinical update #61, Daniel Griffin reviews a modeling of future hospitalizations and deaths by vaccination rates and non pharmaceutical intervention scenarios, performance evaluation of r...
8 Touko 202143min
TWiV 751: Sputnik spat and furin in ferrets
TWiV examines the claim by Brazil's ANVISA that the Sputnik vaccine contains replication-competent adenovirus, and a role for the furin cleavage site in SARS-CoV-2 spike for efficient reproduction in ...
6 Touko 20211h 33min
TWiV 750: To err is viral
The TWiVmeisters discuss how copy-back defective viral genomes might modulate the clinical outcome of respiratory syncytial virus infection, and detection of antibodies to henipa- and filo-like viruse...
2 Touko 20212h 9min
TWiV 749: COVID-19 clinical update #60 with Dr. Daniel Griffin
In COVID-19 clinical update #60, Daniel Griffin summarizes CDC guidance for summer camps, how to protect yourself when fully vaccinated, updated recommendation for J&J vaccine, declining global case f...
1 Touko 202140min
TWiV 748: SARS-CoV-2 gets a sense of humoral
A TWiV trio explains a method for sequencing single genomes of SARS-CoV-2 and its use to explore in-host evolution drive by antibody responses, and incidence of cerebral venous thrombosis in COVID-19 ...
25 Huhti 20211h 46min
